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Background: Community-acquired pneumonia (CAP) is a significant cause of morbidity and mortality in all age
groups worldwide. It may be classified as mild/moderate or severe, the latter usually requiring hospitalisation.
Although, there are many studies reported in relation to CAP, there is relatively little known about the treatment of
CAP and its antibiotic use in Mongolia. The study aim was to evaluate prescribing practices for the treatment of
mild/moderate CAP in Mongolia with respect to national prescribing guidelines.
Methods: Written prescriptions with a written diagnosis of CAP included were collected prospectively and
sequentially for ten weeks from a purposefully selected sample of community pharmacies in rural and urban areas
of Mongolia. The data collected included the patient’s age, gender, medication details, frequency and number of
doses prescribed. Evaluation was with respect to the Mongolian Standard Treatment Guidelines (2005, 2008).
Statistical differences between groups were tested using the Chi-squared and Fisher’s exact tests.
Results: Prescriptions were collected from 22 pharmacies and represented the prescribing practices of 118 doctors.
The study enrolled 394 (193 adults and 201 children) patients, with a median age for children of 2.0 years (range:
0.03-12) and adults of 33.0 years (range: 13–92).
The most commonly prescribed drugs were aminopenicillins, vitamins, and mucolytics, with the median number of
drugs being three per prescription. Inappropriate drug selection was similar for adults (57.7%) and children (56.6%),
and the major reason for an overall frequency of inappropriate prescribing for adults was 89.0% and for children
78.0%. Doctors in urban areas prescribed more inappropriate drugs than those in rural areas for both children and
adults, p = .0014. The proportion of prescribed injections was 28.4% for adults and 9.0% for children, and for adults
was significantly higher in urban areas. The prescribing standard for non-hospitalized patients in Mongolia states
that injections should not be prescribed.
Conclusions: The high level of inappropriate prescribing for mild/moderate CAP highlights the need to develop
comprehensive and reliable procedures nationwide to improve prescribing practices in Mongolia.Background
Community-acquired lower respiratory tract infection
(LRTI) is a common cause of acute illness both in devel-
oping and developed countries. The spectrum of the dis-
ease ranges from a mild mucosal colonisation or infection,
acute bronchitis or acute exacerbation of chronic bron-
chitis/chronic obstructive pulmonary disease, to over-
whelming symptoms in the patient presenting with severe* Correspondence: gereltuya.dorj@postgrad.curtin.edu.au
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reproduction in any medium, provided the orcommunity-acquired pneumonia. Pneumonia is broadly
classified into two categories: community-acquired (CAP)
and hospital-acquired. CAP is a significant cause of mor-
bidity and mortality in all age groups, especially the elderly
[1], which is a patient population group that continues to
grow. Death rates associated with CAP have not changed
greatly, partly because of increased numbers of patients
with comorbidity and patients at risk [2].
Rational drug use occurs when an appropriate drug is
prescribed and administered according to the appropriate
dosage regimen and the drug should be affordable, avail-
able, dispensed correctly, in correct doses at adequate. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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drug use is conformity with standard treatment guidelines.
Moreover, rational dispensing correlates with drug supply
procedures and also the competency and knowledge of
the health care provider. The World Health Organisation
(WHO) was the first to launch a major step (Model Essen-
tial Drug List) towards the rational use of drugs in 1977
[3]. This list was designed to help countries to develop
their own national lists. Later, the International Network
for the Rational Use of Drugs (INRUD) was established to
conduct multidisciplinary research to promote the rational
use of drugs [4].
Common examples of irrational drug use include the
prescribing of antibiotics for viral infections and excessive
or unnecessary use of injections. The consequences of ir-
rational drug use include poor or limited quality of care
[5,6], high cost of therapy [7,8] and increased incidence of
adverse effects such as prolonged morbidity, mortality,
drug toxicity, hospitalization for longer periods, antibiotics
resistant to microorganisms and the associated infections
[9,10]. Antibiotics are one of the most commonly used
treatments in modern medicine [11]. Excessive usage of
antibiotics can be costly, and may have a large cost impact
when there is a limited drug budget. Although it is difficult
to estimate, the global sale of antibiotics is reported as 6 to
21% of the pharmaceutical market, 3 to 25% of total pre-
scriptions [12], and 15 to 30% of drug expenditure [13].
As recommended by the Australian Commission on
Safety and Quality in Healthcare, antimicrobial use should
be optimised by managing through a number of interven-
tions, often referred to as antimicrobial stewardship pro-
grams [14]. An essential core to implement antimicrobial
stewardship programs is monitoring of prescribing with
respect to the guidelines on appropriate use of antibiotics,
including information regarding appropriate selection, do-
sing, route, and duration of antimicrobial therapy [15].
Other interventions include the restriction of selected an-
tibiotics and “stop-orders” after predetermined time pe-
riods. The goals of an antimicrobial stewardship program
include optimization of clinical outcomes while minimiz-
ing unintended consequences of antimicrobial use such as
toxicity, and the emergence of resistance. Moreover, it is
aimed to reduce unnecessary costs associated with health
care [16].
At present, clinical guidelines are widely available in
many countries [17,18]. These guidelines should consider
different risk factors, such as age, comorbidity and initial
clinical severity [19] and there should be evidence-based
implementation strategies at a local level in each country.
In accordance with WHO initiatives, the National
Essential Drug List of Mongolia was first published in
1991 and it has subsequently been revised five times [20].
Generic drugs are promoted by the Government through
its existing legislation. CAP is a significant disease thatrequires urgent appropriate management, including anti-
biotics. There is relatively little known about the treatment
of mild/moderate CAP in Mongolia, and in particular, the
drugs used. This study is the first community-based as-
sessment of the treatment of non-hospitalized patients
with mild/moderate CAP in Mongolia. The primary aim
of this study was to evaluate the appropriateness of pre-
scribing practices for mild/moderate CAP based on the
criteria established by the standard treatment guidelines
in Mongolia. A secondary objective was to investigate the




Prescriptions submitted to community pharmacies in
Mongolia with only a diagnosis of mild/moderate CAP
written on the prescription by the prescriber, were col-
lected prospectively and sequentially. According to the
National Guideline for Good Prescribing and Dispensing
Practice of Mongolia (Regulations), all physicians must
record the diagnosis on the prescription. A data collection
form was developed and translated from English to
Mongolian and back-translated into English, in order to
assure the accuracy of data collection. All prescribed drugs,
including their dosage, duration, route of administration
and demographic information of patients were extracted
from the prescriptions. Each drug was evaluated for
rational prescribing based on the Standard Treatment
Guidelines of Mongolia (2005, 2008) [21,22]. Appropriate-
ness was assessed for each of the following indicators: drug
selection, dosage form, single dose, frequency, prescribed
quantity and prescribed duration. A drug was classified as
“inappropriate” if any one of these indicators were not in
accordance with the standard treatment guidelines. The
assessment was based on a sequential cascading down
effect, e.g. if first indicator was “inappropriate” then drug
would be excluded from further analysis and would not
appear in the second indicator, etc.
Site selection
Mongolia, a developing country located between Russia
and China, is one of the most sparsely populated countries
in the world, with a total population of 2.75 million. It is
divided into 21 provinces (aimag) and the capital city is
Ulaanbaatar. About 40% of the population lives in the
capital city.
According to the “National Standard Requirement for
Pharmacy” [23], a main community pharmacy can have up
to two branches. The main pharmacy can only be owned
by pharmacists, but the pharmacy branch can be owned by
a pharmacist or pharmacy technician. According to the lat-
est statistics, there were 543 community pharmacies [24].
In addition, 302 remote pharmacies (soum) were registered
Table 1 Standard treatment guidelines for the management of mild/moderate CAP in Mongolia
Adults Mild/ moderate CAP
Mongolian Standard Treatment
Guidelines for Common Diseases:
Pneumonia (2005)
Oral amoxicillin (ampicillin) 500 mg every 6 hours, or erythromycin 500 mg every 6 hours
Children
Treatment Guidelines for Common
Diseases in Children: Pneumonia
(Mongolian Standard) MNS 5836:2008
Infants: Benzylpenicillin, aminoglycoside
(gentamicin) injectionUp to five years old: Semi-
synthetic penicillin (50 mg/kg/4 times) +
gentamicin 7.5 mg/kg/once)-injection If
available chloramphenicol (75 mg/kg/3 times a
day) *Additional option: Cephalosporin II-III
If considered necessary, any of the following could be
prescribed: Salbutamol, euphyllin, epinephrine
Prednisolone, dexamethasone Vitamin C, A or E
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government [24]. These can be managed by pharmacists or
pharmacy technicians.
The site selection was based on the WHO Operational
package for assessing, monitoring and evaluating country
pharmaceutical situations [25]. The principle of selecting
private pharmacies in the city and in each province was to
select the closest private pharmacy to each public health
facility surveyed. However, branches and RDFs were ex-
cluded in this study because branches of the pharmacies
are legally restricted to Over the Counter (OTC) drugs
and due to limited budget.
A convenience selection method was applied for pharma-
cies in rural areas based on discussion with local profes-
sionals. The sites selected were privately owned community
pharmacies in towns in eight provinces (Bayankhongor,
Bulgan, Govi-Altai, Khovsgol, Ovorkhangai, Sukhbaatar, Tuv,
Uvs) and the remainder in the capital city (Ulaanbaatar).
Period of the study
The study was conducted in the winter season (mean
temperature −25°C) over a period of 10 weeks, from
January until March, 2010, which is a period with a high
prevalence of acute respiratory tract infections.
The study protocol was approved by the Human
Research Ethics Committee, Curtin University, Western
Australia (PH-11-2010).
Data analysis
All data were entered and analysed using SPSS software
(version 18.0). The drugs prescribed for the diagnosis ofTable 2 Demographic characteristics of participants
Characteristics Number (%) Gender Med
Adults 193 (48.9) F=97 (50.3%) 33.0
Children 201 F= 98 (48.8%) 2.0
(51.0)
Totalmild/moderate CAP were analysed against recommenda-
tions included in the Standard Treatment Guidelines for
CAP (2005, 2008) and the National Guidelines for Good
Prescribing Practice of Mongolia (Table 1). Decisions re-
garding appropriateness were made separately by two of
the authors (GD and validated by BS). Differences were re-
solved by consensus. Differences in prescribing practices
between adults and children and urban and rural areas
were tested for statistical significance using the Chi-square
statistic and Fisher’s Exact test. A p-value < 0.05 was taken
to indicate a statistically significant association.
Data analysis of the prescribing practices for children
was limited by the lack of information in the guidelines
for children aged 6–15 year old (Table 1).
Results
Study sites
Thirty pharmacies consisting of 20 in the Ulaanbaatar
area and 10 in eight of the provinces were selected for
inclusion in the study, of which 22 consented. This rep-
resented a response rate of 73%. All pharmacies that did
not consent were in the city area stating they were too
busy to participate.
Selection and characteristics of participants
The study enrolled 394 (193 adults and 201 children) par-
ticipants who were diagnosed with mild/moderate CAP.
The prescriptions represented the prescribing practices of
118 doctors.
Table 2 shows the demographic characteristics of parti-














Aminopenicillins 163 16.0 J01CA04




Paracetamol 57 3.5 N02BE01
Ciprofloxacin 52 4.7 J01MA02
Salbutamol 37 3.4 R03CC02
Erythromycin 36 3.3 J01FA01




Calcium gluconate 32 2.9 A12AA03
Cefazoline 31 2.8 J01DB04
Sodium chloride 31 2.8 A12CA01
Chlorphenamine 29 2.6 R06AB04
Chitamona 23 2.1 Herbal
Vitamin B Complex 17 1.6 A11EA
aLocal product containing Glycyrrhiza uralensis Fisch, Thermopsis dahurica Czefr.
Table 4 Number of drugs prescribed per prescription
Category Adults Children
Urban Rural Urban Rural
No. of patients 124 69 111 90
No. of prescribed drugs 368 188 301 243
Min 1.00 1.00 1.00 1.00
Median 3.00 3.00 3.00 3.00
Max 7.00 6.00 7.00 6.00
Mean 2.99 2.72 2.71 2.73
Std Dev 1.20 0.87 1.12 0.91
p value* =0.63 =0.98
*p-value was calculated based on number of patients vs. number of drugs in
different areas.
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age for children of 2.0 years (range: 0.03-12) and adults of
33.0 years (range: 13–92). Male adults (49.7%) were in
similar numbers to females (50.3%).
Prescribing pattern of doctors
A total of 1100 drugs were prescribed for the 394 partici-
pants, with the most commonly prescribed being ami-




Figure 1 Appropriateness level of prescribing for patients with mild/followed by vitamins, mucolytics (bromhexine), ciproflox-
acin and paracetamol (Table 3).
There was a low level of poly-pharmacy with the median
number of drugs being three per prescription. There
was no significant difference in the number of drugs pre-
scribed for adults (p=0.63) and children, or in urban and
rural locations (p = .98) (Table 4).
Frequency of inappropriate prescribing
The overall level of inappropriate prescribing for all pa-
tients based upon application of the standard treatment
guidelines was 845 (84.0%) (Figure 1). A total of 95 were
not assessable because of lack of information about drug
selection, dosage form, dose, frequency and duration in
the current guidelines for children aged between 6 to 15
years (Figure 2).
The results of the assessment of prescription categories
for patients with mild/moderate CAP are shown for























Figure 2 Inappropriateness levels of drug selection for patients with mild/ moderate CAP in urban and rural areas (y axis refers to
number of drugs prescribed).
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ence between inappropriate prescribing for adults and
children, χ [2] (1, n=1100) =22.8, p < .001. Relatively more
adults were prescribed inappropriate drugs, largely as a re-
sult of the dosage frequency prescribed.
Inappropriate drug selection was the major reason for
inappropriate prescribing for patients with CAP, with
the extent of inappropriate drug selection similar for
children (56.6%) and adults (57.7%). Doctors in urban
areas prescribed a higher frequency of inappropriate
drugs than those in rural areas for the population stud-
ied, χ [2] (1, n=575) =10.25, p = .0014 (Figure 2).
Prescribing level of injectables
The proportion of drugs (n=1100) prescribed as injections
was 28.4% for adults and 9.0% for children. Prescribing of
injectables was significantly higher for adults in urban
areas compared with rural areas χ [2] (1, n=556)=21.7,
DF=1, p = < .001, but the difference between urban and
rural prescribing of injectables was not significant for chil-
dren (Table 7). In the case of antibiotics, the proportion of
injectables prescribed was 34.7% in the urban (83/239)Table 5 Assessment of the prescriptions for children with mil
Category Drug selection Dosage form
n (%) n (%)
A 195 (43.4) 171 (87.7)




Total assessable 449 195
Total 544 290
A- Appropriate, IA- Inappropriate, NAI- No assessable guideline information, OPD- Over
aIncludes the number of appropriately selected drugs from the previous column.
*If the first indicator was “inappropriate”, then the prescription item classification w
not appear in the second indicator.and 18.5% in rural areas (31/168). Since the current guide-
lines for ambulatory care does not allow any use of inject-
ables for outpatients with moderate/mild CAP, this use of
injections is non-compliant with one of the current pre-
scribing standards for Mongolia [26]. Moreover, gentami-
cin is recommended for the treatment of mild/moderate
CAP for children and it was prescribed for outpatients
with mild/moderate CAP. However, this is available only
as injectable, so the guideline recommendation is non-
compliant with the prescribing standard.
Discussion
This is the first study to explore prescribing practices for
mild/moderate CAP in Mongolia by comparing drugs pre-
scribed with respect to government initiated treatment
guidelines. The study revealed only low levels of poly-
pharmacy with the average number of drugs prescribed
being three per patient. This is consistent with a previous
assessment of prescribing practices of the pharmaceutical
sector undertaken in 2009 [27].
High levels of inappropriate prescribing were identified
when evaluation occurred with respect to governmentd/moderate CAP*
Dose Frequency Final result
n (%) n (%) n (%)
102 (59.6) 99 (97.1) 99 (22.1)
(see below) 3 (2.9) 350 (78.0)
1 (0.6) - -




prescribed dose, UPD- Underprescribed dose.
as “inappropriate” and this drug was excluded from further analysis and would
Table 6 Assessment of the prescriptions for adults with mild/moderate CAP*
Category Drug selection Dosage form Dose Frequency Final result
n (%) n (%) n (%) n (%) n (%)
A 235 (42.3) 192 (81.7) 120 (62.5) 61 (50.8) 61 (11.0)
IA 321 (57.7) 43 (18.3)a - 59 (49.2) 495 (89.0)
OPD - - 18 (9.4) - -
UPD - - 54 (28.1) - -
Total 556 235 192 120 556
A- Appropriate, IA- Inappropriate, OPD- Overprescribed dose, UPD- Underprescribed dose.
aIncludes the number of appropriately selected drugs in inappropriate dosage forms only.
*If the first indicator was “inappropriate”, then the prescription item classification was “inappropriate” and this drug was excluded from further analysis and would
not appear in the second indicator.
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with 84% of drugs inappropriately prescribed. The major
reason causing inappropriate prescribing for both adults
and children was inappropriate drug selection.
In a South African study examining the adherence to
treatment guidelines for CAP, empirical antibiotic treat-
ment for severe CAP accorded with local guidelines for
14 patients (8%) only. The remaining 168 patients (92%)
were given treatment that was inconsistent with the guide-
lines [28].
The evaluation of prescriptions indicated diverse pre-
scribing practices for patients with CAP. In most cases
(93.4%) at least one antibiotic was prescribed. Cipro-
floxacin, cotrimoxazole and ketotifen (antihistamine) were
most commonly prescribed. These were inconsistent with
the current guidelines and showed a lack of practical
adoption and implementation of the treatment guidelines.
Possible explanations for these findings could include lack
of knowledge, attitude and awareness of the guidelines. In
addition, some prescribers under-prioritise the guidelines
because they may feel time and financial pressures from
external factors [29,30].
Different prescribing practices between rural and urban
areas were observed, with doctors in rural areas pres-
cribing more appropriately than their counterparts in
urban areas. Anecdotal statements from local health pro-
fessionals suggested this could relate to the smaller popu-
lation and possibly a better control of prescribing and
dispensing practice. Another possible reason may relate toTable 7 Proportion of prescribed injections for
participants with mild/moderate CAP





Urban adults 128 (23.0) 240 (43.2) 368 < .001
Rural adults 30 (5.4) 158 (28.4) 188
Urban
children
32 (5.9) 269 (49.4) 301 .141
Rural
children
17 (3.1) 226 (41.5) 243
aPercentage of drugs.rural practitioners being less accessible to visits from
pharmaceutical companies or receiving their literature.
There were reports from doctors and pharmacists about
financial incentives from the pharmaceutical companies in
the form of extra income from prescribing and dispensing
their drugs. This practice is illegal in Mongolia; however it
is still common in some countries [31-33].
Unfortunately about 8% of all drugs prescribed for chil-
dren with CAP in this study could not be assessed due to
non-existent information in the current guidelines for
children aged 5 to 16 years. This indicates that evidence-
based treatment of children with CAP cannot be assured
in the absence of guidelines.
Treatment guidelines are an important component of as-
suring appropriate drug use [34] and for the decision mak-
ing process in health care practice. The need for and
importance of well-documented, standardized guidelines is
recognized as essential for the successful treatment of CAP
[35]. However, despite being promulgated by well-regarded
institutions, often compliance with national guidelines for
treatment of CAP is poor [36,37]. The implementation of
guidelines depends on the clarity of the statement and
adaptability into practice. In addition, guidelines need to
be readily assessable and endorsed by senior practitioners.
A number of interventions to improve the prescribing be-
haviour can be found from the literature. However, a
Cochrane review indicated that there was insufficient evi-
dence to support the choice of intervention [38]. While
single interventions may be as effective as multiple ones
due to existing health infrastructure in developed coun-
tries, multiple intervention packages have been shown to
be more beneficial in less developed countries [34]. These
intervention packages often include building infrastructure,
such as supervisory systems, that are likely to increase their
impact [34]. In addition, tailoring interventions to target
specific barriers to compliance was reported to be effective
in improving professional practice [39-41].
The use of unnecessary injections is a common occur-
rence in developing countries and it is widely recognized
that unsafe healthcare injections can transmit HBV [42],
HCV [43], HIV [44], viral haemorrhagic fever and other
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level of injections for the treatment of mild/moderate
CAP was approximately 18% of all drugs. Moreover,
inconsistency between guidelines was observed. Genta-
micin is recommended in the current treatment guide-
line for children with CAP [21]. However, it is available
only as an injection and this recommendation does not
comply with the Good Prescribing and Dispensing
Practice regulations of Mongolia [46]. According to a
study of injection practices in Mongolia, the average
number of injections was 13 per patient for one year in
Mongolia in 2002, which was the highest rate of injec-
tion usage in the Western Pacific Region [47]. Most of
the injections (antibiotics) were administered for the
treatment of pneumonia. Regardless of the govern-
ment’s effort to develop guidelines to promote and im-
plement rational drug use, there are still problems with
unnecessary and inappropriate use of injections in com-
munity settings and with the current guidelines.
Limitations
The study has two main limitations. Firstly, the estimates
were based on a one point in time observation completed
in the winter period. Secondly, although the study aimed
to provide a representative sampling in location and size,
only about 4% of all main community pharmacies could
be included. However it is the habits of prescribers that
were assessed in this study. The study assessed the pre-
scribing practice of 118 prescribers which represents 15%
of all family group practitioners in Mongolia. Therefore,
the results should be representative of the prescribing
practice for the treatment of CAP at the national and
rural levels.
Conclusions
The study has shown unacceptably high levels of inappro-
priate prescribing for mild/moderate CAP in Mongolia
and in addition has highlighted the inadequacy and incon-
sistency of the current treatment guidelines. The findings
have important implications for the health status of pa-
tients being treated for mild/moderate CAP and suggest
the need for appropriate interventions to be developed
and introduced by authorities to address the issues raised.
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